Oncolytics appoints EVP John McAdory and VP Biostatistics Yujun Wu, grants inducement awards

ONCOLYTICS BIOTECH INC

John McAdory named EVP Strategy & Operations; previously VP Clinical Ops at CG Oncology (Nasdaq: CGON).
Yujun Wu named VP Head of Biostatistics; previously Head of Biostatistics at Morphic Therapeutic.
Inducement awards: McAdory 500k options + 300k RSUs; Wu 300k options; exercise price $0.97.
Appointments enhance execution for late-stage pancreatic, colorectal, and anal cancer trials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.